GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Total Assets

The Cooper (MEX:COO) Total Assets : MXN252,132 Mil (As of Jan. 2025)


View and export this data going back to 2014. Start your Free Trial

What is The Cooper Total Assets?

The Cooper's Total Assets for the quarter that ended in Jan. 2025 was MXN252,132 Mil.

Warning Sign:

If a company builds assets at 16.2% a year, faster than its revenue growth rate of 9.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, The Cooper's average Total Assets Growth Rate was 1.90% per year. During the past 3 years, the average Total Assets Growth Rate was 8.70% per year. During the past 5 years, the average Total Assets Growth Rate was 16.20% per year. During the past 10 years, the average Total Assets Growth Rate was 12.80% per year.

During the past 13 years, The Cooper's highest 3-Year average Total Assets Growth Rate was 56.70%. The lowest was -67.70%. And the median was 12.70%.

Total Assets is connected with ROA %. The Cooper's annualized ROA % for the quarter that ended in Jan. 2025 was 3.45%. Total Assets is also linked to Revenue through Asset Turnover. The Cooper's Asset Turnover for the quarter that ended in Jan. 2025 was 0.08.


The Cooper Total Assets Historical Data

The historical data trend for The Cooper's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Total Assets Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143,347.05 197,417.02 228,099.17 210,478.12 246,690.70

The Cooper Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206,674.34 205,579.24 225,178.53 246,690.70 252,131.76

The Cooper Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

The Cooper's Total Assets for the fiscal year that ended in Oct. 2024 is calculated as

Total Assets=Total Equity (A: Oct. 2024 )+Total Liabilities (A: Oct. 2024 )
=161925.825+84764.872
=246,691

The Cooper's Total Assets for the quarter that ended in Jan. 2025 is calculated as

Total Assets=Total Equity (Q: Jan. 2025 )+Total Liabilities (Q: Jan. 2025 )
=167662.197+84469.566
=252,132

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (MEX:COO) Total Assets Explanation

Total Assets is connected with ROA %.

The Cooper's annualized ROA % for the quarter that ended in Jan. 2025 is

ROA %=Net Income (Q: Jan. 2025 )/( (Total Assets (Q: Oct. 2024 )+Total Assets (Q: Jan. 2025 ))/ count )
=8606.42/( (246690.697+252131.764)/ 2 )
=8606.42/249411.2305
=3.45 %

Note: The Net Income data used here is four times the quarterly (Jan. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

The Cooper's Asset Turnover for the quarter that ended in Jan. 2025 is

Asset Turnover
=Revenue (Q: Jan. 2025 )/( (Total Assets (Q: Oct. 2024 )+Total Assets (Q: Jan. 2025 ))/ count )
=19900.796/( (246690.697+252131.764)/ 2 )
=19900.796/249411.2305
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

The Cooper Total Assets Related Terms

Thank you for viewing the detailed overview of The Cooper's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.